KRW 7970.0
(-1.85%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | -13.07 Billion | -62.85 Billion | -50.9 Billion | -114.48 Billion | -24.95 Billion | 2.05 Billion |
Net Income | -202.22 Billion | -224.7 Billion | -200.69 Billion | -82.06 Billion | -14.09 Billion | -112.87 Billion |
Depreciation & Amortization | 86.72 Billion | 82.87 Billion | 68.87 Billion | 17.97 Billion | 4.63 Billion | 1.09 Billion |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 39.36 Billion | 18.06 Billion | 43.3 Billion | -50.02 Billion | -15.93 Billion | -3.46 Billion |
Other non-cash items | 63.05 Billion | 60.9 Billion | 37.6 Billion | -371.85 Million | 448.82 Million | 117.29 Billion |
Investing Cash Flow | -19.56 Billion | -3.65 Billion | -74.05 Billion | -578.89 Billion | -40.81 Billion | -211.86 Billion |
Investments in PPE | -10.08 Billion | -14.23 Billion | -90.02 Billion | -556.38 Billion | -215.55 Billion | -27.97 Billion |
Acquisitions | 22.56 Million | 9.09 Million | 73.58 Million | -4.32 Billion | -457.72 Million | 18.16 Billion |
Investment purchases | -15.49 Billion | -2 Billion | -73.58 Million | -41.99 Billion | -772.02 Billion | -502.63 Billion |
Sales/Maturities of investments | 2 Billion | 15.27 Billion | 7.56 Billion | 20.73 Billion | 948.67 Billion | 319.17 Billion |
Other Investing Activities | 3.98 Billion | -2.7 Billion | 8.4 Billion | 3.08 Billion | -1.45 Billion | -18.59 Billion |
Financing Cash Flow | 37.64 Billion | 34.42 Billion | 127.39 Billion | 735.3 Billion | 68.93 Billion | 176.52 Billion |
Debt repayment | -48.92 Billion | -35.66 Billion | -90.48 Billion | -157.6 Billion | -68.96 Billion | -72.92 Billion |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | -6.22 Billion |
Common Stock Issuance | - | -40.77 Million | - | - | -25.1 Million | 215.63 Billion |
Other Financing Activities | -11.27 Billion | 70.12 Billion | 217.87 Billion | 892.9 Billion | 137.92 Billion | 33.8 Billion |
Accounts receivables | 24.6 Billion | -2.59 Billion | 33.9 Billion | -21.41 Billion | -5.94 Billion | 412.04 Million |
Accounts payables | -78.64 Million | -1.2 Billion | 7.64 Billion | 494.49 Million | 31 Million | 24.23 Million |
Inventory | 2.51 Billion | -9.05 Million | -2.67 Billion | 185.58 Million | -4.03 Billion | 24.36 Million |
Other working capital | 12.33 Billion | 21.87 Billion | 4.43 Billion | -29.28 Billion | -5.99 Billion | -3.48 Billion |
Cash at beginning of period | 28.6 Billion | 60.68 Billion | 58.18 Billion | 16.3 Billion | 13.14 Billion | 45.46 Billion |
Cash at end of period | 33.63 Billion | 28.6 Billion | 60.68 Billion | 58.18 Billion | 16.3 Billion | 13.14 Billion |
Capital Expenditure | -10.08 Billion | -14.23 Billion | -90.02 Billion | -556.38 Billion | -215.55 Billion | -27.97 Billion |
Effect of forex changes on cash | 39 Million | 2.29 Million | 59.27 Million | -49.55 Million | - | 965.47 Million |
Net cash flow / Change in cash | 5.03 Billion | -32.08 Billion | 2.5 Billion | 41.87 Billion | 3.16 Billion | -32.32 Billion |
Free Cash Flow | -23.16 Billion | -77.09 Billion | -140.92 Billion | -670.87 Billion | -240.5 Billion | -25.92 Billion |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -2.49 Billion | -38.38 Billion | -202.22 Billion | -31.25 Billion | -29.49 Billion | -47.81 Billion |
Depreciation & Amortization | 21.33 Billion | 20.21 Billion | 86.72 Billion | 21.63 Billion | 21.79 Billion | 21.79 Billion |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 6.78 Billion | -1.19 Billion | 39.36 Billion | 8 Billion | -31.81 Billion | 12.95 Billion |
Other non-cash items | -4.34 Billion | 68.72 Billion | 63.05 Billion | 6.19 Billion | 30.68 Billion | 18.06 Billion |
Investing Cash Flow | -1.56 Billion | -2.58 Billion | -19.56 Billion | -4.62 Billion | 5.67 Billion | -2.98 Billion |
Investments in PPE | 294.94 Million | -1.39 Billion | -10.08 Billion | -372.88 Million | -4.8 Billion | -2.84 Billion |
Acquisitions | - | - | 22.56 Million | 1.49 Million | -65.74 Million | 86.8 Million |
Investment purchases | -5.46 Million | - | -15.49 Billion | -5.33 Billion | -156.07 Million | -3 Billion |
Sales/Maturities of investments | - | - | 2 Billion | 1.00 | 65.74 Million | -86.8 Million |
Other Investing Activities | -1.85 Billion | -1.19 Billion | 3.98 Billion | 1.08 Billion | 10.64 Billion | 2.86 Billion |
Financing Cash Flow | -16.42 Billion | -5.23 Billion | 37.64 Billion | 1.27 Billion | 11.36 Billion | -3.7 Billion |
Debt repayment | -7.56 Billion | -4.59 Billion | -48.92 Billion | -3.14 Billion | -1.83 Billion | -9.73 Billion |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -8.86 Billion | - | -11.27 Billion | 4.42 Billion | 13.19 Billion | 6.02 Billion |
Accounts receivables | -3.39 Billion | 3.6 Billion | 24.6 Billion | 2.43 Billion | -404.3 Million | 29.39 Billion |
Accounts payables | 258.11 Million | -1.06 Billion | -78.64 Million | -2.22 Billion | 559.04 Million | 2.68 Billion |
Inventory | 772.54 Million | -2.89 Billion | 2.51 Billion | 200.59 Million | -906.52 Million | 2.13 Billion |
Other working capital | 9.4 Billion | -840.24 Million | 12.33 Billion | 7.59 Billion | -31.06 Billion | -21.25 Billion |
Cash at beginning of period | 34.48 Billion | 33.63 Billion | 28.6 Billion | 32.57 Billion | 24.25 Billion | 25.94 Billion |
Cash at end of period | 37.8 Billion | 34.48 Billion | 33.63 Billion | 33.63 Billion | 32.57 Billion | 24.25 Billion |
Capital Expenditure | 294.94 Million | -1.39 Billion | -10.08 Billion | -372.88 Million | -4.8 Billion | -2.84 Billion |
Effect of forex changes on cash | 16.71 Million | 83.9 Million | 39 Million | -169.28 Million | 118.67 Million | -4.48 Million |
Net cash flow / Change in cash | 3.31 Billion | 849.14 Million | 5.03 Billion | 1.06 Billion | 8.31 Billion | -1.69 Billion |
Free Cash Flow | 21.58 Billion | 7.18 Billion | -23.16 Billion | 4.21 Billion | -13.64 Billion | 2.15 Billion |
DIABIO
GENPHARMA
GATE
GGAAF
QBAT
HBIE